R. Michael Kleine is President and Chief Executive Officer of Miramar Labs, Inc. Mr. Kleine has been with Miramar Labs since February 2014. Mr. Kleine is an established leader with a proven track record of success in leading several global biomedical companies. With nearly two decades of experience in C-suite positions, he has experience commercializing new technologies, increasing revenues and growing organizations. Previous positions held include President and CEO roles with EndoGastric Solutions; Sorin Biomedical; Biosensors International Group Ltd., a publicly traded company; Thermo Cardiosystems, which was acquired by Thoratec; and MicroVention, a startup, which was acquired by Terumo.
Interview with the President and CEO: Miramar Labs, Inc. (OTCMKTS:MRLB)
July 29, 2016